High Lead Exposure Associated With Higher Blood Pressure in Haiti: a Warning Sign for Low-Income Countries.


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
01 2022
Historique:
entrez: 8 12 2021
pubmed: 9 12 2021
medline: 20 1 2022
Statut: ppublish

Résumé

Cardiovascular disease is the leading cause of death in lower-income countries including Haiti. Environmental lead exposure is associated with high blood pressure and cardiovascular mortality in high-income countries but has not been systematically measured and evaluated as a potential modifiable cardiovascular risk factor in lower-income countries where 6.5 billion people reside. We hypothesized lead exposure is high in urban Haiti and associated with higher blood pressure levels. Blood lead levels were measured in 2504 participants ≥18 years enrolled in a longitudinal population-based cohort study in Port-au-Prince. Lead screening was conducted using LeadCare II (detection limit ≥3.3 µg/dL). Levels below detection were imputed by dividing the level of detection by √2. Associations between lead (quartiles) and systolic blood pressure and diastolic blood pressure were assessed, adjusting for age, sex, obesity, smoking, alcohol, physical activity, income, and antihypertensive medication use. The median age of participants was 40 years and 60.1% were female. The geometric mean blood lead level was 4.73µg/dL, 71.1% had a detectable lead level and 42.3% had a blood lead level ≥5 µg/dL. After multivariable adjustment, lead levels in quartile four (≥6.5 µg/dL) compared with quartile 1 (<3.4 µg/dL) were associated with 2.42 mm Hg (95% CI, 0.36-4.49) higher systolic blood pressure and 1.96 mm Hg (95% CI, 0.56-3.37) higher diastolic blood pressure. In conclusion, widespread environmental lead exposure is evident in urban Haiti, with higher lead levels associated with higher systolic and diastolic blood pressure. Lead is a current and potentially modifiable pollutant in lower-income countries that warrants urgent public health remediation. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03892265.

Identifiants

pubmed: 34878898
doi: 10.1161/HYPERTENSIONAHA.121.18250
pmc: PMC8667279
mid: NIHMS1752947
doi:

Substances chimiques

Lead 2P299V784P

Banques de données

ClinicalTrials.gov
['NCT03892265']

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

283-290

Subventions

Organisme : FIC NIH HHS
ID : D43 TW011972
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI098627
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL143788
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069421
Pays : United States

Références

Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Circulation. 2009 Sep 22;120(12):1056-64
pubmed: 19738141
J Hypertens. 2019 Apr;37(4):685-695
pubmed: 30817448
J Hum Hypertens. 2002 Feb;16(2):123-31
pubmed: 11850770
Environ Health Perspect. 2006 Oct;114(10):1538-41
pubmed: 17035139
Lancet Public Health. 2018 Apr;3(4):e177-e184
pubmed: 29544878
Lancet. 2018 Nov 10;392(10159):1923-1994
pubmed: 30496105
Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H454-65
pubmed: 18567711
Front Public Health. 2018 Dec 19;6:367
pubmed: 30619808
Chemosphere. 2020 Mar;243:125412
pubmed: 31995873
J Public Health Manag Pract. 2019 Jan/Feb;25 Suppl 1, Lead Poisoning Prevention:S23-S30
pubmed: 30507766
Public Health Rep. 2019 Jan/Feb;134(1):47-56
pubmed: 30426830
JAMA. 2003 Mar 26;289(12):1523-32
pubmed: 12672769
Crit Rev Clin Lab Sci. 2017 Nov - Dec;54(7-8):506-528
pubmed: 29214886
Clin Toxicol (Phila). 2013 Nov;51(9):828-33
pubmed: 24134533
J Expo Sci Environ Epidemiol. 2013 Jan-Feb;23(1):81-7
pubmed: 22617721
J Am Heart Assoc. 2015 Oct 27;4(10):e002276
pubmed: 26508742
BMC Public Health. 2020 Nov 1;20(1):1633
pubmed: 33131500
Circulation. 2006 Sep 26;114(13):1388-94
pubmed: 16982939
N Engl J Med. 1983 Jun 9;308(23):1373-7
pubmed: 6188954
Kidney Int. 2004 Dec;66(6):2329-36
pubmed: 15569323
J Am Heart Assoc. 2017 Feb 3;6(2):
pubmed: 28159816

Auteurs

Lily D Yan (LD)

Division of General Internal Medicine, Department of Medicine (L.D.Y., J.K., K.F.W., M.L.M.), Weill Cornell Medicine, New York, New York.
Center for Global Health, Department of Medicine (L.D.Y., V.R., M.H.L., J.K., K.F.W., C.E.S., M.M., J.W.P., D.W.F., M.L.M.), Weill Cornell Medicine, New York, New York.

Vanessa Rouzier (V)

Center for Global Health, Department of Medicine (L.D.Y., V.R., M.H.L., J.K., K.F.W., C.E.S., M.M., J.W.P., D.W.F., M.L.M.), Weill Cornell Medicine, New York, New York.
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti (V.R., J.L.P., A.A., S.S.-P., M.D., J.W.P.).

Jean Lookens Pierre (JL)

Division of General Internal Medicine, Department of Medicine (L.D.Y., J.K., K.F.W., M.L.M.), Weill Cornell Medicine, New York, New York.
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti (V.R., J.L.P., A.A., S.S.-P., M.D., J.W.P.).

Myung Hee Lee (MH)

Division of General Internal Medicine, Department of Medicine (L.D.Y., J.K., K.F.W., M.L.M.), Weill Cornell Medicine, New York, New York.

Paul Muntner (P)

Department of Epidemiology, University of Alabama at Birmingham School of Public Health (P.M.) Birmingham, AL.

Patrick J Parsons (PJ)

Laboratory of Inorganic and Nuclear Chemistry, Division of Environmental Health Sciences, Wadsworth Center, New York State Department of Health, Albany, NY (P.J.P.).
Department of Environmental Health Sciences, School of Public Health, University at Albany, Rensselaer, New York (P.J.P.).

Alexandra Apollon (A)

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti (V.R., J.L.P., A.A., S.S.-P., M.D., J.W.P.).

Stephano St-Preux (S)

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti (V.R., J.L.P., A.A., S.S.-P., M.D., J.W.P.).

Rodolphe Malebranche (R)

Collège Haïtien de Cardiologie, Port-au-Prince, Haiti (R.M., G.P.).
Medicine and Pharmacology, Université d'État d'Haïti, Port-au-Prince, Haiti (R.M.).

Gerard Pierre (G)

Collège Haïtien de Cardiologie, Port-au-Prince, Haiti (R.M., G.P.).

Evens Emmanuel (E)

Division of General Internal Medicine, Department of Medicine (L.D.Y., J.K., K.F.W., M.L.M.), Weill Cornell Medicine, New York, New York.
École doctorale Société et Environnement, Université Quisqueya, Port-au-Prince, Haiti (E.E.).

Denis Nash (D)

City University of New York Institute for Implementation Science in Population Health (D.N., O.T.).

Justin Kingery (J)

Division of General Internal Medicine, Department of Medicine (L.D.Y., J.K., K.F.W., M.L.M.), Weill Cornell Medicine, New York, New York.
Center for Global Health, Department of Medicine (L.D.Y., V.R., M.H.L., J.K., K.F.W., C.E.S., M.M., J.W.P., D.W.F., M.L.M.), Weill Cornell Medicine, New York, New York.

Kathleen F Walsh (KF)

Division of General Internal Medicine, Department of Medicine (L.D.Y., J.K., K.F.W., M.L.M.), Weill Cornell Medicine, New York, New York.
Center for Global Health, Department of Medicine (L.D.Y., V.R., M.H.L., J.K., K.F.W., C.E.S., M.M., J.W.P., D.W.F., M.L.M.), Weill Cornell Medicine, New York, New York.

Caleigh E Smith (CE)

Division of General Internal Medicine, Department of Medicine (L.D.Y., J.K., K.F.W., M.L.M.), Weill Cornell Medicine, New York, New York.
Center for Global Health, Department of Medicine (L.D.Y., V.R., M.H.L., J.K., K.F.W., C.E.S., M.M., J.W.P., D.W.F., M.L.M.), Weill Cornell Medicine, New York, New York.
University of Virginia School of Medicine, Charlottesville, VA (C.E.S.).

Miranda Metz (M)

Center for Global Health, Department of Medicine (L.D.Y., V.R., M.H.L., J.K., K.F.W., C.E.S., M.M., J.W.P., D.W.F., M.L.M.), Weill Cornell Medicine, New York, New York.

Olga Tymejczyk (O)

City University of New York Institute for Implementation Science in Population Health (D.N., O.T.).

Marie Deschamps (M)

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti (V.R., J.L.P., A.A., S.S.-P., M.D., J.W.P.).

Jean W Pape (JW)

Center for Global Health, Department of Medicine (L.D.Y., V.R., M.H.L., J.K., K.F.W., C.E.S., M.M., J.W.P., D.W.F., M.L.M.), Weill Cornell Medicine, New York, New York.
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti (V.R., J.L.P., A.A., S.S.-P., M.D., J.W.P.).

Daniel W Fitzgerald (DW)

Center for Global Health, Department of Medicine (L.D.Y., V.R., M.H.L., J.K., K.F.W., C.E.S., M.M., J.W.P., D.W.F., M.L.M.), Weill Cornell Medicine, New York, New York.

Margaret L McNairy (ML)

Division of General Internal Medicine, Department of Medicine (L.D.Y., J.K., K.F.W., M.L.M.), Weill Cornell Medicine, New York, New York.
Center for Global Health, Department of Medicine (L.D.Y., V.R., M.H.L., J.K., K.F.W., C.E.S., M.M., J.W.P., D.W.F., M.L.M.), Weill Cornell Medicine, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH